Micro Cap Growth Fund
Daily price w/o sales charge as of 04/22/2021
$20.03
$0.10
YTD Returns w/o sales charge as of 04/22/2021
11.90%
Overall Morningstar RatingsSmall Growth
as of 03/31/2021
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 5, 5 and 5 stars among 576, 503 and 379 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 3/31/2021, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 03/31/2021
- Total Net Assets
- $482.62 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 1.33%
- Number of Holdings
- 84
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 12.29% | 166.09% | 38.33% | 35.46% | 20.95% | 12.94% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.06% | 92.77% | 19.82% | 19.91% | 13.10% | - |
| Russell Microcap® Growth Index | 16.86% | 123.08% | 19.72% | 18.82% | 12.46% | - |
| w/ sales charge | 5.85% | 150.85% | 35.63% | 33.87% | 20.24% | 12.62% |
Fund Expense Ratio :
1.33%
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 12.29% | 166.09% | 38.33% | 35.46% | 20.95% | 12.94% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.06% | 92.77% | 19.82% | 19.91% | 13.10% | - |
| Russell Microcap® Growth Index | 16.86% | 123.08% | 19.72% | 18.82% | 12.46% | - |
| w/ sales charge | 5.85% | 150.85% | 35.63% | 33.87% | 20.24% | 12.62% |
Fund Expense Ratio :
1.33%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 03/31/2021View Portfolio
| Holding | Assets |
|---|---|
| Sonos Inc | 2.9% |
| Sleep Number Corp | 2.5% |
| Calix Inc | 2.4% |
| Krystal Biotech Inc | 2.3% |
| Agilysys Inc | 2.1% |
| Cerence Inc | 2.1% |
| Container Store Group Inc/The | 1.9% |
| Ichor Holdings Ltd | 1.9% |
| Quanterix Corp | 1.8% |
| Telos Corp | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/31/2021View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Not Classified | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 12.29% | 166.09% | 38.33% | 35.46% | 20.95% | 12.94% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.06% | 92.77% | 19.82% | 19.91% | 13.10% | - |
| Russell Microcap® Growth Index | 16.86% | 123.08% | 19.72% | 18.82% | 12.46% | - |
| w/ sales charge | 5.85% | 150.85% | 35.63% | 33.87% | 20.24% | 12.62% |
Fund Expense Ratio :
1.33%
Fund Expense Ratio :
1.33%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 12.29% | 166.09% | 38.33% | 35.46% | 20.95% | 12.94% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.06% | 92.77% | 19.82% | 19.91% | 13.10% | - |
| Russell Microcap® Growth Index | 16.86% | 123.08% | 19.72% | 18.82% | 12.46% | - |
| w/ sales charge | 5.85% | 150.85% | 35.63% | 33.87% | 20.24% | 12.62% |
Fund Expense Ratio :
1.33%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.83% | 4.30% |
| 2013 | 78.53% | 52.84% |
| 2012 | 2.35% | 15.17% |
| 2011 | -5.87% | -8.42% |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| 2005 | 2.55% | - |
| 2004 | 25.89% | - |
| 2003 | 49.34% | - |
| 2002 | -30.97% | - |
| 2001 | 16.96% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2021 | 12.29% | - | - | - | 11.90% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% | 79.42% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% | 34.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% | 2.74% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% | 38.43% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% | 2.07% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% | -6.38% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% | 10.83% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% | 78.53% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% | 2.35% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% | -5.87% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% | 33.77% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% | 52.61% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% | -46.45% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% | 22.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% | 25.37% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% | 2.55% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% | 25.89% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% | 49.34% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% | -30.97% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% | 16.96% |
| 2000 | - | - | -4.83% | -19.30% | -30.76% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 03/31/2021
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Sonos Inc | Consumer Discretionary | 2.9% |
| Sleep Number Corp | Consumer Discretionary | 2.5% |
| Calix Inc | Information Technology | 2.4% |
| Krystal Biotech Inc | Health Care | 2.3% |
| Agilysys Inc | Information Technology | 2.1% |
| Cerence Inc | Information Technology | 2.1% |
| Container Store Group Inc/The | Consumer Discretionary | 1.9% |
| Ichor Holdings Ltd | Information Technology | 1.9% |
| Quanterix Corp | Health Care | 1.8% |
| Telos Corp | Information Technology | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Calix Inc | Information Technology | 2.8% |
| Digital Turbine Inc | Information Technology | 2.8% |
| Sonos Inc | Consumer Discretionary | 2.8% |
| Agilysys Inc | Information Technology | 2.7% |
| Cerence Inc | Information Technology | 2.4% |
| PubMatic Inc | Consumer Discretionary | 2.1% |
| Sleep Number Corp | Consumer Discretionary | 2.1% |
| Quanterix Corp | Health Care | 2.1% |
| Magnite Inc | Consumer Discretionary | 2.1% |
| Krystal Biotech Inc | Health Care | 2.0% |
| Silvergate Capital Corp | Financials | 1.9% |
| Sprout Social Inc | Information Technology | 1.7% |
| CEVA Inc | Information Technology | 1.6% |
| CryoPort Inc | Health Care | 1.6% |
| Chart Industries Inc | Industrials | 1.6% |
| Rigel Pharmaceuticals Inc | Health Care | 1.5% |
| Shockwave Medical Inc | Health Care | 1.4% |
| Telos Corp | Information Technology | 1.4% |
| Westport Fuel Systems Inc | Industrials | 1.4% |
| SI-BONE Inc | Health Care | 1.4% |
| Ichor Holdings Ltd | Information Technology | 1.3% |
| Castle Biosciences Inc | Health Care | 1.3% |
| Malibu Boats Inc | Consumer Discretionary | 1.3% |
| Rambus Inc | Information Technology | 1.3% |
| Celsius Holdings Inc | Consumer Staples | 1.3% |
| Montrose Environmental Group Inc | Industrials | 1.3% |
| Scholar Rock Holding Corp | Health Care | 1.3% |
| Axonics Modulation Technologies Inc | Health Care | 1.3% |
| Inspire Medical Systems Inc | Health Care | 1.2% |
| Turning Point Brands Inc | Consumer Staples | 1.2% |
| Beam Therapeutics Inc | Health Care | 1.2% |
| Cardlytics Inc | Information Technology | 1.2% |
| CareDx Inc | Health Care | 1.1% |
| Five Prime Therapeutics Inc | Health Care | 1.1% |
| Shyft Group Inc/The | Industrials | 1.1% |
| Gentherm Inc | Consumer Discretionary | 1.1% |
| eXp World Holdings Inc | Real Estate | 1.1% |
| nLight Inc | Information Technology | 1.1% |
| Raven Industries Inc | Industrials | 1.1% |
| NanoString Technologies Inc | Health Care | 1.1% |
| OrthoPediatrics Corp | Health Care | 1.1% |
| Rocket Pharmaceuticals Inc | Health Care | 1.1% |
| Container Store Group Inc/The | Consumer Discretionary | 1.0% |
| Viant Technology Inc | Information Technology | 1.0% |
| Seres Therapeutics Inc | Health Care | 1.0% |
| Intra-Cellular Therapies Inc | Health Care | 1.0% |
| Constellation Pharmaceuticals Inc | Health Care | 1.0% |
| Trupanion Inc | Financials | 1.0% |
| elf Beauty Inc | Consumer Staples | 0.9% |
| Myovant Sciences Ltd | Health Care | 0.9% |
| Pulmonx Corp | Health Care | 0.9% |
| Impinj Inc | Information Technology | 0.9% |
| Central Garden & Pet Co | Consumer Staples | 0.8% |
| LGI Homes Inc | Consumer Discretionary | 0.8% |
| Pliant Therapeutics Inc | Health Care | 0.8% |
| Criteo SA | Communication Services | 0.8% |
| Trillium Therapeutics Inc | Health Care | 0.8% |
| Veracyte Inc | Health Care | 0.8% |
| Overstock.com Inc | Consumer Discretionary | 0.7% |
| Insmed Inc | Health Care | 0.7% |
| Turning Point Therapeutics Inc | Health Care | 0.7% |
| TPI Composites Inc | Industrials | 0.7% |
| Ameresco Inc | Industrials | 0.7% |
| TG Therapeutics Inc | Health Care | 0.7% |
| Karuna Therapeutics Inc | Health Care | 0.7% |
| Inari Medical Inc | Health Care | 0.7% |
| 908 Devices Inc | Information Technology | 0.7% |
| Simulations Plus Inc | Health Care | 0.7% |
| GenMark Diagnostics Inc | Health Care | 0.6% |
| Evoqua Water Technologies Corp | Industrials | 0.6% |
| Health Catalyst Inc | Health Care | 0.6% |
| Upland Software Inc | Information Technology | 0.6% |
| Willdan Group Inc | Industrials | 0.6% |
| fuboTV Inc | Information Technology | 0.6% |
| Rush Enterprises Inc | Industrials | 0.5% |
| Hydrofarm Holdings Group Inc | Industrials | 0.5% |
| Atlas Air Worldwide Holdings Inc | Industrials | 0.5% |
| Orchard Therapeutics plc | Health Care | 0.5% |
| Ontrak Inc | Health Care | 0.5% |
| Zuora Inc | Information Technology | 0.5% |
| Outset Medical Inc | Health Care | 0.5% |
| Pacific Biosciences of California Inc | Health Care | 0.4% |
| Spartan Acquisition Corp II | Undefined | 0.4% |
| Stoke Therapeutics Inc | Health Care | 0.4% |
| Adaptimmune Therapeutics Plc | Health Care | 0.3% |
| Golden Nugget Online Gaming Inc | Consumer Discretionary | 0.1% |
| SEER Inc | Health Care | 0.1% |
| Ooma Inc | Communication Services | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/31/2021
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
1.5%
|
|
| Real Estate |
0.1%
|
|
| Utilities | 0.0% | |
| Not Classified |
 1.9%
|
|
| Consumer Discretionary |
3.1%
|
|
| Consumer Staples |
1.1%
|
|
| Energy | 0.0% | |
| Financials |
0.9%
|
|
| Health Care |
5.7%
|
|
| Industrials |
2.6%
|
|
| Information Technology |
0.3%
|
|
| Materials | 0.0% |
Portfolio Details as of 03/31/2021
- Total Net Assets
- $482.62 M
- Number of Holdings
- 84
- Weighted Average Market Cap.
- 2.5 B
- P/B Ratio
- 6.2x
- P/E Ratio
- 43.7x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Contributors & Detractors as of 03/31/2021
Contributors
| Holding | Contribution |
|---|---|
| Sleep Number Corp | 1.2% |
| Sonos Inc | 1.1% |
| Magnite Inc | 1.1% |
| Macerich Co. | 1.0% |
| PubMatic Inc | 0.9% |
Detractors
| Holding | Contribution |
|---|---|
| Trupanion Inc | -0.5% |
| Pulmonx Corp | -0.4% |
| Constellation Pharmceti | -0.4% |
| Myovant Sciences Ltd | -0.4% |
| Cardlytics Inc | -0.3% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Micro Cap Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 04/22/2021
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/22/2021 | 11/23/2021 | 11/23/2021 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/22/2021 | 11/23/2021 |
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 04/22/2021
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $21.25 |
| $50,000 to $99,999 | 4.75% | 4.00% | $21.03 |
| $100,000 to $249,999 | 3.95% | 3.25% | $20.85 |
| $250,000 to $499,999 | 2.75% | 2.25% | $20.60 |
| $500,000 to $999,999 | 1.95% | 1.75% | $20.43 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $20.03 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 03/31/2021
| 1.33% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||